Global

Adding an IVD specimen matrix? Map extraction, detection and clinical evidence to each configuration, then assess the bridge and regulatory change separately.

Interruptions during device programming are routine. How RA/QA and software teams specify, verify, and document the resume state to catch silent reversions and blank fields.

Report discordant IVD study results without relabeling the original comparison. See FDA’s recommendations, a synthetic specimen ledger, and separate resolver reporting.

A practical evidence table linking medical device battery runtime claims to operating workload, battery service age, and alarm conditions, with FDA source boundaries.

How device teams distinguish duplicate HL7 result resends from corrections, specify receiver behavior, and verify the evidence under FDA software guidance.

How medical device teams specify and verify numeric equivalence across displayed, stored, and exported unit conversions under FDA software guidance, QMSR 820.10(c), and NIST SP 811.

How to specify and verify medical device storage-full behavior across recording continuity, user warnings, and data export under FDA software guidance and QMSR.

How to specify UTC or offset-bearing timestamps and verify repeated-hour event ordering, interval math, and Part 11 audit trails before the daylight saving time fall-back transition.

Determine which medical device settings and state must survive a power dip or battery swap, derive essential performance criteria, and structure verification under the QMSR.

Choose a defensible operating altitude for medical electrical equipment, with clearance calculations, thermal evidence, and separate EMS and aircraft assessments.

Learn how to author compliant medical device rework instructions, determine reverification scope under ISO 13485 clause 8.3.4 and QMSR 820.3(b), and avoid undocumented fixes.

How medical device manufacturers structure customer transition plans when software reaches end of support, mapping required evidence, IMDRF milestones, and surviving duties.

How FDA guidance and the EU MDR decide which device models one test report covers, and which records justify an untested size or configuration.

When a laboratory may adopt an IVD manufacturer's reference interval, when CLIA requires verification or establishment, and what ISO 15189 adds only for accredited laboratories.

A practical decision guide to UDI placement across medical device packaging levels under FDA, EU MDR, and TGA rules, covering carriers, unique identifiers, and shipper exemptions.

How medical device RA/QA teams reconcile units, ISO symbols, and released versions across translation cycles before artwork issuance under FDA QMSR 820.45 and EU MDR GSPR 23.

When a supplier change notice omits affected lots, dates, or technical details, device QA must hold unverified product, issue an evidence request, and halt close-out until facts are verified.

Evaluate whether a configurable EDC study build can reconstruct device models, firmware versions, deficiencies, and endpoint records for FDA and EU MDR trials.

Operational guide to ISO 20417:2026: FDA Rec# 5-149 complete recognition, the July 1 2029 DoC transition window, ISO 15223-1, 21 CFR 801, and EU MDR GSPR 23.

FDA DHT clinical investigation guide: investigational device vs remote measurement tool under 21 CFR 812, fit-for-purpose V&V, and August 2026 DDM status.